04:04 PM EDT, 06/25/2025 (MT Newswires) -- Health care stocks were rising late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.1%.

The iShares Biotechnology ETF (IBB) shed 0.5%.

In corporate news, Envoy Medical ( COCH ) shares rose 4.2% after it said Wednesday it appointed Robert Potashnick as interim chief financial officer.

Plus Therapeutics ( PSTV ) shares surged 74%. The company said Wednesday that the US Food and Drug Administration has cleared its investigational new drug application for Reyobiq, paving the way for a phase 1/2a trial targeting pediatric patients with recurrent or progressive high-grade glioma and ependymoma.

GSK (GSK) and Bharat Biotech International said Wednesday that they plan to progressively cut the price of the RTS,S malaria vaccine by more than half to less than $5 by 2028. GSK shares were down 1%.

Lifeward ( LFWD ) shares tumbled 37% after it said Wednesday it has priced a public offering of 4 million ordinary shares and warrants to buy another 4 million shares at $0.65 per share and warrant for gross proceeds of about $2.6 million.

GlucoTrack ( GCTK ) shares jumped 26%. The company said Wednesday that the first human trial of its continuous blood glucose monitor met all primary and secondary endpoints.